Page last updated: 2024-08-25

zoledronic acid and Histiocytosis, Langerhans-Cell

zoledronic acid has been researched along with Histiocytosis, Langerhans-Cell in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's4 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ito, E; Kobayashi, A; Kudo, K; Tanaka, T; Terui, K1
Aihara, T; Furukawa, R; Kikkawa, I; Morimoto, A; Watanabe, H1
Merola, C; Merola, G; Montella, L; Palmieri, G; Petillo, L1
Alloh Amichia, YC; Giumelli, B; Le Bars, P; Soueidan, A1
Drabick, J; Harvey, H; Lipton, A; Sivendran, S1
Baumann, A; Czerny, C; Eisenmenger, G; Ewers, R; Hoffmann, M; Moser, D; Pietschmann, P; Wutzl, A1

Other Studies

6 other study(ies) available for zoledronic acid and Histiocytosis, Langerhans-Cell

ArticleYear
Zoledronic acid for relapsed Langerhans cell histiocytosis with isolated skull bone lesion.
    Pediatrics international : official journal of the Japan Pediatric Society, 2019, Volume: 61, Issue:3

    Topics: Biomarkers; Bone Density Conservation Agents; Bone Diseases; Child; Female; Histiocytosis, Langerhans-Cell; Humans; Magnetic Resonance Imaging; Recurrence; Skull; Zoledronic Acid

2019
Langerhans cell histiocytosis case with dense metaphyseal band sign.
    Pediatrics international : official journal of the Japan Pediatric Society, 2013, Volume: 55, Issue:1

    Topics: Bone Density Conservation Agents; Child; Diphosphonates; Female; Histiocytosis, Langerhans-Cell; Humans; Imidazoles; Knee Joint; Radiography; Spinal Diseases; Thoracic Vertebrae; Zoledronic Acid

2013
Zoledronic acid in treatment of bone lesions by Langerhans cell histiocytosis.
    Journal of bone and mineral metabolism, 2009, Volume: 27, Issue:1

    Topics: Adult; Bone and Bones; Bone Density Conservation Agents; Diphosphonates; Disease Progression; Female; Histiocytosis, Langerhans-Cell; Humans; Imidazoles; Male; Middle Aged; Radionuclide Imaging; Young Adult; Zoledronic Acid

2009
[Prosthetic rehabilitation after osteonecrosis of the jaws due to histiocytosis X and treatment with bisphosphonates apropos of a case].
    Odonto-stomatologie tropicale = Tropical dental journal, 2010, Volume: 33, Issue:132

    Topics: Adult; Alendronate; Bone Density Conservation Agents; Denture Design; Denture, Partial, Fixed; Denture, Partial, Temporary; Diphosphonates; Female; Histiocytosis, Langerhans-Cell; Humans; Imidazoles; Jaw, Edentulous, Partially; Mandibular Diseases; Osteonecrosis; Pamidronate; Risk Factors; Tooth Extraction; Zoledronic Acid

2010
Treatment of Langerhans cell histiocytosis bone lesions with zoledronic acid: a case series.
    International journal of hematology, 2011, Volume: 93, Issue:6

    Topics: Adult; Bone and Bones; Bone Density Conservation Agents; Bone Diseases; Diphosphonates; Female; Histiocytosis, Langerhans-Cell; Humans; Imidazoles; Male; Pain; Radiography; Treatment Outcome; Young Adult; Zoledronic Acid

2011
Osteonecrosis of the jaws and bisphosphonate treatment in cancer patients.
    Wiener klinische Wochenschrift, 2006, Volume: 118, Issue:15-16

    Topics: Adult; Aged; Biopsy; Bone Density Conservation Agents; Breast Neoplasms; Diphosphonates; Female; Follow-Up Studies; Histiocytosis, Langerhans-Cell; Humans; Imidazoles; Injections, Intravenous; Jaw Diseases; Magnetic Resonance Imaging; Male; Mandible; Mandibular Diseases; Maxilla; Maxillary Diseases; Middle Aged; Multiple Myeloma; Osteonecrosis; Pamidronate; Radiography, Panoramic; Radionuclide Imaging; Retrospective Studies; Risk Factors; Time Factors; Tomography, X-Ray Computed; Zoledronic Acid

2006